Vet Guide to Entyce & Elura in 2025: Safe Appetite Stimulation for Dogs and Cats 🐾

Vet Guide to Entyce® & Elura® in 2025 🐾

Hello, I’m **Dr Duncan Houston, BVSc**, founder of Ask A Vet. This in-depth 2025 guide helps you understand **Entyce®** (for dogs) and **Elura®** (for cats), both FDA-approved oral solutions that stimulate appetite via **capromorelin**, a ghrelin-receptor agonist. You’ll find everything you need—mechanism, dosing, side-effects, safety advice, and real-world tips. 💊🐶🐱

📘 What Is Capromorelin?

Capromorelin is a **ghrelin-receptor agonist** that mimics the hunger hormone, signaling the brain to increase appetite and promoting growth hormone release.

✅ Approved Uses

• Entyce® (dogs): FDA-approved since May 2016 to stimulate appetite in dogs with inappetence.
• Elura® (cats): Approved in October 2020 to help manage weight loss in cats with chronic kidney disease.

📐 Dosing & Administration

• Entyce® (dogs): 3 mg/kg (1.4 mg/lb) once daily as a flavored 30 mg/mL oral solution, using the provided syringe.
• Elura® (cats): Once-daily dose via 20 mg/mL solution, dosing weight-based per vet instructions.
• Shake well and administer orally; offer food 30 minutes after for cats.
• Missed dose? Give as soon as possible unless it's almost time for next dose—never double dose.

⏱ Onset & Duration

Pets may begin eating within 1–2 hours, with owners typically noticing significant increase by Day 4.

⚠️ Common Side Effects

• GI upset: vomiting, diarrhea, gassiness, nausea.
• Increased thirst and urination, drooling, belly pain, lethargy.
• Cats: appetite loss, behavior changes, anemia, dehydration (Elura®).
• Rare: swollen paws, liver enzyme changes—needs monitoring during long-term use in dogs.

🚫 Contraindications & Precautions

• Avoid in pets with hypersensitivity to capromorelin; cats with acromegaly should not receive Elura®.
• Use caution in pets with liver or kidney disease, especially when using Entyce® in dogs.
• Not evaluated in breeding, pregnant, or lactating animals.

🔗 Drug Interactions

Watch for interactions with amiodarone, diltiazem, cimetidine, erythromycin, ketoconazole, rifampin, phenobarbital, and itraconazole—inform your vet about all medications.

🩺 Monitoring & Follow‑Up

• Track daily appetite and body weight changes.
• Cats: monitor hydration, GI symptoms, energy levels.
• Dogs on prolonged treatments: consider periodic lab checks for liver/kidney function.

🌍 Real‑World Insights

In a 171-dog study, ~70% of Entyce®-treated dogs showed increased appetite by Day 4 vs 45% for controls—well tolerated over 4 consecutive days.

❓ FAQ

Can my cat take Entyce®?

No—Entyce® is only approved for dogs. Cats should receive Elura®.

What if my pet vomits after dosing?

If within 15 minutes, re-dose once. Otherwise, continue next scheduled dose.

How long can I safely use these?

Entyce® studied up to 12 months in healthy dogs; Elura® safe for chronic CKD cases. Vet may recommend periodic lab monitoring.

Will it cause weight gain without food intake?

No—capromorelin only stimulates appetite; nutrition must be provided via adequate food intake.

📌 Final Takeaways

• Entyce® (dogs) and Elura® (cats) use capromorelin to safely stimulate appetite.
• Dosing: daily oral liquid (Entyce® 3 mg/kg; Elura® weight-based), deliciously flavored, with visible results within days.
• Side-effects are mainly GI and mild; serious reactions uncommon but warrant vet attention.
• Not for hypersensitive or acromegalic cats, or pregnant/lactating pets; monitor hydration, liver/kidney labs as needed.
• Ideal for use in chronic conditions, improving nutrition & quality of life in 2025 and beyond.

Considering Entyce® or Elura® for your pet? Download the Ask A Vet app for dosing tracking, reminder alerts, side-effect monitoring, and 24/7 veterinary support—ensuring your pet eats well and thrives in 2025. 🐾❤️